AI in Genomics Market to Reach USD 6.5 Billion by 2035 | Precision Medicine, Next-Generation Sequencing & AI Drive Growth

➤ Market Overview

According to Market Genics, the AI in Genomics Market is estimated at USD 0.6 Billion in 2025 and is projected to reach USD 6.5 Billion by 2035, expanding at a robust CAGR of 27.8% during the forecast period. The market is experiencing substantial growth as artificial intelligence (AI), machine learning (ML), deep learning, and advanced bioinformatics revolutionize genomic research and precision medicine. AI-powered genomics solutions are enabling researchers and healthcare providers to analyze complex genomic datasets faster, identify disease-associated genetic variants, accelerate drug discovery, and support personalized treatment decisions. Rising investments in genomic sequencing, increasing adoption of next-generation sequencing (NGS) technologies, growing demand for precision medicine, and expanding applications of AI in oncology, rare diseases, and pharmacogenomics are key factors fueling market expansion. Additionally, collaborations between biotechnology companies, pharmaceutical firms, and AI technology providers are accelerating innovation across the genomics ecosystem.

Get Free Sample PDF Brochure: https://marketgenics.co/download-report-sample/ai-in-genomics-market-89545?utm_source=Open+pr&utm_medium=ruchika

➤ Growth Snapshot

The AI in Genomics Market is witnessing rapid adoption due to the growing volume of genomic data generated worldwide and the need for advanced computational tools to extract meaningful biological insights. AI-driven platforms improve genome sequencing analysis, variant interpretation, biomarker discovery, disease prediction, and drug target identification while reducing analysis time and operational costs. The increasing integration of cloud computing, high-performance computing (HPC), multi-omics analytics, digital pathology, and precision healthcare is further enhancing the capabilities of AI-enabled genomics platforms. Government initiatives supporting genomics research and large-scale population sequencing projects are expected to create significant growth opportunities through 2035.

➤ Market Key Players

• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Tempus AI
• NVIDIA Corporation
• Google LLC
• Microsoft Corporation
• IBM Corporation
• Oracle Corporation
• Qiagen N.V.
• F. Hoffmann-La Roche Ltd.
• SOPHiA GENETICS
• Bio-Rad Laboratories Inc.
• Agilent Technologies Inc.
• BGI Genomics
• PacBio

Buy Now Premium Research Report: https://marketgenics.co/buy/ai-in-genomics-market-89545?utm_source=Open+pr&utm_medium=ruchika

➤ Market Segmentation

The AI in Genomics Market is segmented based on component, deployment mode, technology, application, end user, and region. By component, the market includes software, AI platforms, and services. Based on deployment mode, it is categorized into cloud-based and on-premise solutions. By technology, the market comprises machine learning, deep learning, natural language processing (NLP), computer vision, and predictive analytics. Applications include genome sequencing, variant interpretation, biomarker discovery, drug discovery, disease diagnosis, precision medicine, pharmacogenomics, agricultural genomics, and population genomics. End users include pharmaceutical companies, biotechnology firms, academic and research institutes, hospitals, clinical laboratories, genomic sequencing centers, and contract research organizations (CROs).

➤ Market Analysis and Insights

Artificial intelligence is transforming genomics by enabling rapid analysis of large-scale genomic datasets and uncovering complex genetic relationships that were previously difficult to identify. AI-powered algorithms enhance genomic sequencing accuracy, automate variant classification, improve biomarker identification, and accelerate therapeutic discovery. The increasing convergence of AI, genomics, transcriptomics, proteomics, and multi-omics research is driving innovation in personalized healthcare and precision medicine. Pharmaceutical companies are increasingly using AI to identify novel drug targets, optimize clinical trials, and develop personalized therapies based on genetic profiles. Furthermore, cloud-based genomic analytics platforms and AI-enabled clinical decision support systems are improving collaboration between researchers and healthcare providers, positioning AI in genomics as a critical technology for the future of life sciences and healthcare.

➤ Segmentation and Targeting

The AI in Genomics Market report is designed for pharmaceutical companies, biotechnology firms, genomic sequencing companies, healthcare providers, AI software developers, clinical laboratories, hospitals, academic research institutions, contract research organizations (CROs), precision medicine companies, investors, and government health agencies. The report provides strategic insights for stakeholders involved in AI-powered genomics, precision medicine, bioinformatics, next-generation sequencing (NGS), biomarker discovery, genetic testing, drug development, and molecular diagnostics. It serves as a valuable resource for organizations seeking to capitalize on emerging opportunities within the rapidly evolving genomics landscape.

Browse In-depth Market Research Report: https://marketgenics.co/reports/ai-in-genomics-market-89545?utm_source=Open+pr&utm_medium=ruchika

➤ Geographical Landscape

North America dominates the AI in Genomics Market owing to advanced genomic research infrastructure, high adoption of AI technologies, substantial investments in biotechnology, and the presence of leading pharmaceutical and genomics companies. The United States remains the largest contributor due to extensive precision medicine initiatives, genomic research programs, and AI innovation. Europe holds a significant market share, supported by strong government funding, collaborative genomics projects, and increasing adoption of AI-enabled healthcare solutions across Germany, the United Kingdom, France, Switzerland, and the Netherlands. The Asia-Pacific region is expected to register the fastest growth during the forecast period, driven by expanding genomic sequencing capabilities, increasing healthcare digitization, growing biotechnology investments, and supportive government initiatives across China, Japan, India, South Korea, Singapore, and Australia. Latin America and the Middle East & Africa are also witnessing growing adoption of AI-driven genomics technologies as healthcare systems continue to modernize.

➤ Questions Answered by the Report

• What is the current size of the AI in Genomics Market?
• What will be the market value by 2035?
• What is the projected CAGR during 2025-2035?
• Which AI technologies are driving innovation in genomics?
• What are the major applications of AI in genomic research and precision medicine?
• Who are the leading companies operating in the AI in Genomics Market?
• Which region dominates the global market?
• Which region is expected to witness the fastest growth?
• What are the key growth drivers, challenges, and emerging opportunities?
• How will AI, next-generation sequencing (NGS), and precision medicine reshape the genomics industry over the next decade?

➤ Discover More Research Reports By MarketGenics:

Connected Ambulance Systems Market - https://www.openpr.com/news/4585511/connected-ambulance-systems-market-to-reach-usd-0-6-billion

Smart ICU Systems Market - https://www.openpr.com/news/4585515/smart-icu-systems-market-to-reach-usd-27-6-billion-by-2035-as-ai

AI-based Pathology Market - https://www.openpr.com/news/4585520/ai-based-pathology-market-to-reach-usd-0-8-billion-by-2035-as

Smart Implants Market - https://www.openpr.com/news/4585526/smart-implants-market-to-reach-usd-7-2-billion-by-2035-as-ai

AI in Hospital Operations Market - https://www.openpr.com/news/4585528/ai-in-hospital-operations-market-to-reach-usd-61-5-billion-by-2035

About MarketGenics

MarketGenics is a global market research and business advisory firm empowering decision-makers across startups, Fortune 500 companies, non-profit organizations, universities, and government institutions. The company delivers comprehensive market intelligence, industry analysis, and strategic insights across diverse sectors.

MarketGenics publishes detailed industry research reports combining granular quantitative analysis with expert insights on market trends, competitive landscapes, and emerging opportunities. These reports help organizations make informed strategic decisions, identify growth opportunities, and support sustainable business development.

In addition to research publications, MarketGenics supports organizations with strategic insights on product development, application modeling, market expansion strategies, and identifying niche growth opportunities.

Contact:
Mr. Debashish Roy
MarketGenics Global Research

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co

This release was published on openPR.